Cargando…

Absorption of Direct Oral Anticoagulants in Cancer Patients after Gastrectomy

Direct oral anticoagulants (DOACs) are safe and effective in cancer patients treated for venous thromboembolism (VTE) or atrial fibrillation (AF). Gastrectomy is the treatment of choice in patients with localized upper gastrointestinal cancer. DOACs are absorbed in the upper gastrointestinal tract,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Puhr, Hannah C., Ilhan-Mutlu, Aysegül, Preusser, Matthias, Quehenberger, Peter, Kyrle, Paul A., Eichinger, Sabine, Eischer, Lisbeth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8951361/ https://www.ncbi.nlm.nih.gov/pubmed/35336036 http://dx.doi.org/10.3390/pharmaceutics14030662

Ejemplares similares

Circumstances of provoked recurrent venous thromboembolism: the Austrian study on recurrent venous thromboembolism
por: Puhr, Hannah C., et al.
Publicado: (2019)

Immunotherapy for Esophageal Cancers: What Is Practice Changing in 2021?
por: Puhr, Hannah Christina, et al.
Publicado: (2021)

Prediction of Recurrent Venous Thromboembolism by Clot Lysis Time: A Prospective Cohort Study
por: Traby, Ludwig, et al.
Publicado: (2012)

New Treatment Options for Advanced Gastroesophageal Tumours: Mature for the Current Practice?
por: Puhr, Hannah Christina, et al.
Publicado: (2020)

Hematocrit and the Risk of Recurrent Venous Thrombosis: A Prospective Cohort Study
por: Eischer, Lisbeth, et al.
Publicado: (2012)

Recent Advances in the Systemic Treatment of Localized Gastroesophageal Cancer
por: Puhr, Hannah Christina, et al.
Publicado: (2023)

Risk of venous thromboembolism during rehabilitation of patients with spinal cord injury
por: Eichinger, Sabine, et al.
Publicado: (2018)

New emerging targets in cancer immunotherapy: the role of LAG3
por: Puhr, Hannah Christina, et al.
Publicado: (2019)

Clinical characteristics and comparison of the outcome in young versus older patients with upper gastrointestinal carcinoma
por: Puhr, Hannah Christina, et al.
Publicado: (2020)

Viennese risk prediction score for Advanced Gastroesophageal carcinoma based on Alarm Symptoms (VAGAS score): characterisation of alarm symptoms in advanced gastro-oesophageal cancer and its correlation with outcome
por: Puhr, Hannah Christina, et al.
Publicado: (2020)

Elevated Free Thyroxine Levels Are Associated with Poorer Overall Survival in Patients with Gastroesophageal Cancer: A Retrospective Single Center Analysis
por: Puhr, H. C., et al.
Publicado: (2019)

PD-L1 and HER2 Expression in Gastroesophageal Cancer: a Matched Case Control Study
por: Beer, Andrea, et al.
Publicado: (2020)

Systemic inflammatory biomarkers as prognostic tools in patients with gastroesophageal adenocarcinoma
por: Puhr, Hannah C., et al.
Publicado: (2023)

d‐Dimer Levels Over Time and the Risk of Recurrent Venous Thromboembolism: An Update of the Vienna Prediction Model
por: Eichinger, Sabine, et al.
Publicado: (2014)

NephroCheck data compared to serum creatinine in various clinical settings
por: Pajenda, Sahra, et al.
Publicado: (2015)

Thyroid Hormone Replacement Therapy Is Associated with Longer Overall Survival in Patients with Resectable Gastroesophageal Cancer: A Retrospective Single-Center Analysis
por: Puhr, Hannah C., et al.
Publicado: (2021)

Safety of direct oral anticoagulants in patients with advanced liver disease
por: Semmler, Georg, et al.
Publicado: (2021)

Plasma levels of platelet-enriched microRNAs change during antiplatelet therapy in healthy subjects
por: Krammer, Teresa L., et al.
Publicado: (2022)

Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination
por: Greinacher, Andreas, et al.
Publicado: (2021)

Oral Anticoagulants after Heart Transplantation—Comparison between Vitamin K Antagonists and Direct Oral Anticoagulants
por: Darche, Fabrice F., et al.
Publicado: (2023)

MK2 and ETV1 Are Prognostic Factors in Esophageal Adenocarcinomas
por: Jomrich, Gerd, et al.
Publicado: (2018)

How we treat esophageal squamous cell carcinoma
por: Puhr, H.C., et al.
Publicado: (2023)

Development of an alarm symptom-based risk prediction score for localized oesophagogastric adenocarcinoma (VIOLA score)
por: Puhr, H.C., et al.
Publicado: (2022)

New horizons in anticoagulation: Direct oral anticoagulants and their implications in oral surgery
por: Serrano-Sánchez, Víctor, et al.
Publicado: (2017)

Use of New Oral Anticoagulants / Direct Oral Anticoagulants in Malignant Patients
por: Khan, Yusra, et al.
Publicado: (2020)

Factors associated with prescription of oral anticoagulants in the era of direct oral anticoagulants
por: Kataoka, Naoya, et al.
Publicado: (2023)

Reversal of direct oral anticoagulants
por: Almegren, Mosaad
Publicado: (2017)

Lupus anticoagulant testing during anticoagulation, including direct oral anticoagulants
por: Favaloro, Emmanuel J., et al.
Publicado: (2022)

The modified glasgow prognostic score is an independent prognostic indicator in neoadjuvantly treated adenocarcinoma of the esophagogastric junction
por: Jomrich, Gerd, et al.
Publicado: (2018)

Modification of preoperative radiochemotherapy for esophageal cancer (CROSS protocol) is safe and efficient with no impact on surgical morbidity
por: Paireder, Matthias, et al.
Publicado: (2020)

Dabigatran: patient management in specific clinical settings
por: Kyrle, Paul Alexander, et al.
Publicado: (2014)

Tailored Direct Oral Anticoagulation in Patients with Atrial Fibrillation: The Future of Oral Anticoagulation?
por: Samoš, Matej, et al.
Publicado: (2022)

Direct-acting Oral Anticoagulants: An Overview
por: Salem, Hatem H.
Publicado: (2017)

Direct oral anticoagulants and venous thromboembolism
por: Franchini, Massimo, et al.
Publicado: (2016)

Direct oral anticoagulant: Review article
por: Nasiri, Abdulrahman, et al.
Publicado: (2022)

Impact of anticoagulant exposure misclassification on the bleeding risk of direct oral anticoagulants
por: Hempenius, Mirjam, et al.
Publicado: (2021)

Anticoagulant treatment satisfaction with warfarin and direct oral anticoagulants for venous thromboembolism
por: Fang, Margaret C., et al.
Publicado: (2021)

Direct oral anticoagulants: integration into clinical practice
por: Cowell, Richard P W
Publicado: (2014)

Bleeding complications from the direct oral anticoagulants
por: Sholzberg, Michelle, et al.
Publicado: (2015)

Utilization and prescribing patterns of direct oral anticoagulants
por: Whitworth, Maegan M, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_qvecu4th1rgsknh8arg1df0l56